41 – 50 of 65
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Vaccination against encapsulated bacteria in hereditary C2 deficiency results in antibody response and opsonization due to antibody-dependent complement activation.
(
- Contribution to journal › Article
-
Mark
Incidence, prevalence and clinical characteristics of Behcet's disease in southern Sweden.
2012) In Rheumatology (Oxford, England)(
- Contribution to journal › Article
-
Mark
Design of recombinant antibody microarrays for urinary proteomics.
(
- Contribution to journal › Article
-
Mark
Complement in the immunopathogenesis of rheumatic disease.
(
- Contribution to journal › Article
-
Mark
Clinical manifestations and anti-phospholipid antibodies in 712 patients with systemic lupus erythematosus: evaluation of two diagnostic assays.
2012) In Rheumatology (Oxford, England)(
- Contribution to journal › Article
-
Mark
Evolution of disease burden over five years in a multicenter inception systemic lupus erythematosus cohort
(
- Contribution to journal › Article
- 2011
-
Mark
An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA
(
- Contribution to journal › Article
-
Mark
SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis
(
- Contribution to journal › Article